Physician

Bruce Earl Brockstein, MD

According to 2025 Medicare claims, Bruce Brockstein, MD (NPI: 1740349695) practices medical oncology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is ENDEAVOR HEALTH MEDICAL GROUP (NPI: 1497701882; TIN: 363738206) and primary practice location at 60035-2558.

Brockstein's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 306 traditional Medicare patients, billed 1,149 HCPCS/CPT codes, and received $76,925 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 694 prescription claims across 118 beneficiaries totaling $1,607,344 in drug costs, led by Lenvima (Lenvatinib Mesylate). DME data shows 21 claims. Open Payments data shows 2 records totaling $25,415. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $46,961 to $76,925. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,084,084 and ending at $1,607,344. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	268	723	$46,961
2016	258	659	$44,138
2017	248	655	$43,367
2018	282	750	$49,803
2019	287	879	$59,587
2020	284	915	$62,978
2021	326	1,027	$84,636
2022	322	948	$80,139
2023	319	904	$74,001
2024	306	1,149	$76,925

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	71	473	$1,084,084
2016	82	482	$794,864
2017	85	452	$1,133,794
2018	86	436	$971,490
2019	86	475	$517,013
2020	92	615	$572,131
2021	114	694	$928,707
2022	114	669	$1,221,927
2023	123	702	$1,122,272
2024	118	694	$1,607,344

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	48	$4,851
2016	N/R	42	$4,708
2017	N/R	35	$3,533
2018	N/R	22	$2,458
2019	N/R	N/R	N/R
2020	N/R	11	$1,314
2021	N/R	13	$1,436
2022	N/R	66	$6,423
2023	N/R	46	$6,371
2024	N/R	21	$2,985

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	62	62	$154
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	46	77	$121
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	209	504	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	48	53	$55
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	184	343	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenvima	Lenvatinib Mesylate	16	480	$363,928
Mektovi	Binimetinib	13	390	$205,412
Braftovi	Encorafenib	12	360	$194,409
Tafinlar	Dabrafenib Mesylate	12	348	$169,252
Imatinib Mesylate	Imatinib Mesylate	47	1,395	$101,241

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	21	$2,985

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$25,415	Merck Sharp & Dohme LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bruce Earl Brockstein, MD?

Tedicare shows public-source Medicare data for Bruce Earl Brockstein, MD (NPI 1740349695), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bruce Earl Brockstein, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Bruce Earl Brockstein, MD?

Bruce Earl Brockstein, MD is linked to ENDEAVOR HEALTH MEDICAL GROUP (billing NPI 1497701882) in the available physician profile data.

Does Bruce Earl Brockstein, MD have Open Payments data?

Bruce Earl Brockstein, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.